Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W Booz

Showing results (31-40 of 181) with videos related to

Pageof 19
Sort By:
Frontiers in Cardiovascular Medicine|September 12, 2022
Editorial: Non-coding RNAs in heart failureGeorge W Booz, Konstantinos A Theofilatos
Clinical Science (London, England : 1979)|May 22, 2026
Response to the Letter to the EditorFouad A Zouein, George W Booz
Clinical Science (London, England : 1979)|March 13, 2026
Correction: Targeting mitochondria to protect the heart: a matter of balance?Fouad A Zouein, George W Booz
F1000Prime Reports|August 23, 2013
AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handlingFouad A Zouein, George W Booz
European Journal of Pharmacology|November 1, 2020
Science unites a troubled world: Lessons from the pandemicGeorge W Booz, Fouad A Zouein
Clinical Science (London, England : 1979)|December 8, 2025
Targeting mitochondria to protect the heart: a matter of balance?Fouad A Zouein, George W Booz
Journal of Cardiovascular Pharmacology|May 21, 2020
Levosimendan Comes of Age: 20 Years of Clinical UseMazen Kurdi, Piero Pollesello, George W Booz
Journal of Cardiovascular Pharmacology|June 26, 2026
GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease TreatmentGhadir Amin, Babbette LaMarca, George W Booz
Journal of Cardiovascular Pharmacology|August 24, 2022
Cardiovascular Complications of Anticancer Therapy: A Developing Storm in MedicineAlexander Burashnikov, Antonio Abbate, George W Booz
Frontiers in Immunology|January 9, 2019
Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and DiseaseMazen Kurdi, Carlos Zgheib, George W Booz
Pageof 19

Showing results (31-40 of 181) with videos related to

Sort By:
Pageof 19
Frontiers in Cardiovascular Medicine|September 12, 2022
Editorial: Non-coding RNAs in heart failureGeorge W Booz, Konstantinos A Theofilatos
Clinical Science (London, England : 1979)|May 22, 2026
Response to the Letter to the EditorFouad A Zouein, George W Booz
Clinical Science (London, England : 1979)|March 13, 2026
Correction: Targeting mitochondria to protect the heart: a matter of balance?Fouad A Zouein, George W Booz
F1000Prime Reports|August 23, 2013
AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handlingFouad A Zouein, George W Booz
European Journal of Pharmacology|November 1, 2020
Science unites a troubled world: Lessons from the pandemicGeorge W Booz, Fouad A Zouein
Clinical Science (London, England : 1979)|December 8, 2025
Targeting mitochondria to protect the heart: a matter of balance?Fouad A Zouein, George W Booz
Journal of Cardiovascular Pharmacology|May 21, 2020
Levosimendan Comes of Age: 20 Years of Clinical UseMazen Kurdi, Piero Pollesello, George W Booz
Journal of Cardiovascular Pharmacology|June 26, 2026
GLP-1 Gene Therapy Trial for Obesity and Type 2 Diabetes: Towards a New Paradigm for Chronic Disease TreatmentGhadir Amin, Babbette LaMarca, George W Booz
Journal of Cardiovascular Pharmacology|August 24, 2022
Cardiovascular Complications of Anticancer Therapy: A Developing Storm in MedicineAlexander Burashnikov, Antonio Abbate, George W Booz
Frontiers in Immunology|January 9, 2019
Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and DiseaseMazen Kurdi, Carlos Zgheib, George W Booz
Pageof 19